MEDNAX (MD) Tops Q2 EPS by 14c

MEDNAX (NYSE: MD) reported Q2 EPS of $1.02, $0.14 better than the analyst estimate of $0.88. Revenue for the quarter came in at $677 million versus the consensus estimate of $677.02 million.

MEDNAX sees Q315 EPS of $1.07-$1.11, versus the consensus of $0.97.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance
• Medtronic (MDT) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY27 EPS Guidance